Development of Resistance-Associated Mutations After Sotrovimab Administration in High-risk Individuals Infected With the SARS-CoV-2 Omicron Variant
turncovid2022-08-18T16:33:44+01:00Birnie E, Biemond JJ, Appelman B, Bree GJ, Jonges M, Welkers M, Wiersinga WJ. JAMA 2022; gepubliceerd online 1 augustus .